Qanary, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Qanary, LLC - overview
Location
Delaware, OH, US
Primary Industry
Healthcare IT
About
Based in the US, Qanary, LLC, operates as a healthcare-technology company offering a digital second-opinion and diagnostic platform for radiologists and clinicians. Based in Delaware, the US, Qanary, LLC was founded in 2026. The company specializes in healthcare technology, focusing on providing a digital second-opinion and diagnostic platform. Qanary specializes in quantum-enhanced diagnostics, primarily focusing on high-precision cancer detection through its patented agentic engine.
The core product offerings leverage advanced artificial intelligence (AI) methodologies to improve diagnostic accuracy in oncology. These technologies address significant challenges in identifying early-stage malignancies that traditional systems may overlook, impacting patient outcomes. Qanary’s services are designed for a diverse array of healthcare providers, including hospitals, radiology clinics, and research institutions, as well as pharmaceutical companies and startups. Qanary operates on a transparent per-scan pricing model, allowing clinics to utilize its services without hidden enterprise fees.
The firm’s revenue structure primarily revolves around B2B transactions with healthcare providers who implement their diagnostic solutions within existing clinical workflows. Clients pay for individual services related to diagnostic scans powered by Qanary’s quantum-enhanced platform, such as the Live Scan diagnostic service, which delivers high-urgency insights for malignancy detection. The service model typically encompasses both one-time transaction fees for diagnostic reports and potential subscription arrangements for ongoing access to advanced analytics and solutions. The company plans to expand its reach to healthcare facilities across the US and possibly other regions, focusing on clinical efficacy and accessible diagnostics.
Current Investors
Orbit Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Oncology/Cancer Treatment, Medical Software
Website
www.qanary.net
Verticals
Artificial Intelligence, HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Qanary, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | Qanary, LLC | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.